Folasade P. May

ORCID: 0000-0001-6706-8171
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Colorectal Cancer Screening and Detection
  • Gastric Cancer Management and Outcomes
  • Global Cancer Incidence and Screening
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Surgical Treatments
  • Global Health Workforce Issues
  • Diversity and Career in Medicine
  • Liver Disease Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • COVID-19 and healthcare impacts
  • Medical Education and Admissions
  • Diverticular Disease and Complications
  • Colorectal Cancer Treatments and Studies
  • Healthcare Policy and Management
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Esophageal Cancer Research and Treatment
  • Primary Care and Health Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Inflammatory Bowel Disease
  • Food Security and Health in Diverse Populations
  • Global Health and Surgery
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Healthcare cost, quality, practices

Kaiser Permanente
2016-2025

University of California, Los Angeles
2016-2025

VA Greater Los Angeles Healthcare System
2016-2025

UCLA Health
2014-2025

University of Colorado Cancer Center
2020-2024

UCLA Jonsson Comprehensive Cancer Center
2016-2024

Ronald Reagan UCLA Medical Center
2022-2024

Oklahoma State University Center for Health Sciences
2022-2024

University of Colorado Denver
2020-2024

Fielding Graduate University
2023

The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well recommended schedules patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC without defined genetic syndromes. These Insights focus on select recent updates the Guidelines, including a section primary and secondary prevention, provide context panel’s recommendations age initiate in...

10.6004/jnccn.2020.0048 article EN Journal of the National Comprehensive Cancer Network 2020-10-01

This document is an update to the 2014 recommendations for optimizing adequacy of bowel cleansing colonoscopy from US Multi-Society Task Force on Colorectal Cancer, which represents American College Gastroenterology, Gastroenterological Association, and Society Gastrointestinal Endoscopy. The developed consensus statements key clinical concepts addressing important aspects preparation colonoscopy. majority focus individuals at average risk inadequate preparation. However, quality are also...

10.14309/ajg.0000000000003287 article EN The American Journal of Gastroenterology 2025-03-04

Although screening for colorectal cancer (CRC) is recommended all adults aged 50 to 75 years in the United States, there are racial and ethnic disparities who receives screening. Individuals lacking appropriate CRC cite various reasons nonadherence, including lack of provider recommendation The purpose this study evaluate association between patient race as primary reason nonadherence.We conducted a cross-sectional observational individuals from 2009 California Health Interview Survey...

10.1038/ajg.2015.138 article EN The American Journal of Gastroenterology 2015-05-12

The optimal time interval for diagnostic colonoscopy completion after an abnormal stool-based colorectal cancer (CRC) screening test is uncertain. We examined the association between to and CRC outcomes among individuals who underwent screening.

10.1053/j.gastro.2021.01.219 article EN cc-by-nc-nd Gastroenterology 2021-02-02

Liver cancer is one of the most rapidly increasing cancers in United States, and hepatocellular carcinoma (HCC) its common form. Disease burden risk factors differ by sex race/ethnicity, but a comprehensive analysis disparities socioeconomic status (SES) lacking. We examined relative impact sex, SES on HCC incidence, stage, survival.We used Surveillance, Epidemiology, End Results (SEER) 18 data to identify histologically confirmed cases diagnosed between January 1, 2000 December 31, 2015....

10.1158/1055-9965.epi-20-1088 article EN cc-by Cancer Epidemiology Biomarkers & Prevention 2021-03-18

10.1016/j.cgh.2022.05.035 article EN publisher-specific-oa Clinical Gastroenterology and Hepatology 2022-06-16

Young individuals racialized as Black are more likely to die after a colorectal cancer (CRC) diagnosis than White in the United States. This study examined racial disparities receipt of timely and guideline-concordant care among with early-onset CRC.

10.1200/jco.23.00539 article EN Journal of Clinical Oncology 2023-11-08

The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well recommended schedules patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC without defined genetic syndromes. These Insights focus on select recent updates the Guidelines, including a section primary and secondary prevention, provide context panel’s recommendations age which initiate in...

10.6004/jnccn.2024.0047 article EN Journal of the National Comprehensive Cancer Network 2024-09-01

Neisseria gonorrhoeae (NG) infections are a global health burden. NG resistance to cephalosporins, which is increasingly reported, an imminent threat public health. Many hypothesize that commensal species important reservoir for genetic material conferring antimicrobial in NG; however, clinical data lacking.

10.1093/cid/ciz365 article EN Clinical Infectious Diseases 2019-05-01

Abstract Introduction Esophageal cancer (EC) is an aggressive malignancy with poor prognosis. Mortality and disease stage at diagnosis are important indicators of improvements in prevention control. We examined United States trends esophageal adenocarcinoma (EAC) squamous cell carcinoma (ESCC) mortality by race ethnicity. Methods used Surveillance, Epidemiology, End Results (SEER) data to identify individuals histologically confirmed EAC ESCC between 1 January 1992 31 December 2016. For both...

10.1007/s10552-021-01443-z article EN cc-by Cancer Causes & Control 2021-05-18
Douglas J. Robertson Jason A. Dominitz Alexander Beed Kathy D. Boardman Barbara J. Del Curto and 95 more Peter Guarino Thomas F. Imperiale Andrew J. LaCasse Meaghan F. Larson Samir Gupta David A. Lieberman Beata Planeta Aasma Shaukat Shahnaz Sultan Stacy B. Menees Sameer D. Saini Philip Schoenfeld Stephan U. Goebel Erik C. von Rosenvinge György Baffy Ildiko Halasz Marcos Pedrosa Lyn Sue Kahng Riaz Cassim Katarina B. Greer Margaret Kinnard Divya Bhatt Kerry B. Dunbar William V. Harford John A. Mengshol Jed Olson Swati Patel Fadi Antaki Deborah A. Fisher Brian A. Sullivan Christopher Lenza Devang Prajapati Helen Wong Rebecca J. Beyth John Lieb Joseph Manlolo Fernando V. Ona Rhonda A. Cole Natalia Khalaf Charles J. Kahi Divyanshoo R. Kohli Tarun Rai Prateek Sharma Jiannis Anastasiou Curt H. Hagedorn Ronald Fernando Christian S. Jackson M. Mazen Jamal Robert H. Lee Farrukh H. Merchant Folasade P. May Joseph R. Pisegna Endashaw Omer Dipendra Parajuli Adnan Said Toan D. Nguyen Claudio Tombazzi P. A. Feldman Leslie Jacob Rachel Koppelman Kyle P. Lehenbauer Deepak Desai Mohammad F. Madhoun William M. Tierney Minh Q. Ho H Hockman Christopher D. Lopez Emily Carter Paulson Martin Tobi Hugo Pinillos Michele Young Nancy Ho Ranjan Mascarenhas Kirrichai Promrat Pritesh Mutha William M. Pandak Tilak Shah Mitchell L. Schubert Frank S. Pancotto Andrew J. Gawron Amelia E. Underwood Samuel B. Ho Priscilla Magno-Pagatzaurtundua Doris H. Toro Charles Beymer Andrew M. Kaz Jill E. Elwing Jeffrey Gill Susan F. Goldsmith Michael Yao Petr Protiva Heiko Pohl Tassos C. Kyriakides Elaine Kleiner Kathy Sullivan

Importance The Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) randomized clinical trial sought to recruit 50 000 adults into a study comparing colorectal cancer (CRC) mortality outcomes after randomization either an annual fecal immunochemical test (FIT) or colonoscopy. Objective To (1) describe participant characteristics and (2) examine who declined participation because of preference for colonoscopy stool testing (ie, occult blood...

10.1001/jamanetworkopen.2023.21730 article EN cc-by-nc-nd JAMA Network Open 2023-07-11
Coming Soon ...